Old Web
English
Sign In
Acemap
>
Paper
>
A PHASE IB STUDY OF AN ORAL PI3Kδ INHIBITOR LINPERLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA
A PHASE IB STUDY OF AN ORAL PI3Kδ INHIBITOR LINPERLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T CELL LYMPHOMA
2021
Lugui Qiu
Jie Jin
H. Cen
Keshu Zhou
Xiaohong Xu
F. Li
T Wu
Haitao Yang
Zhiqiang Wang
Zhiming Li
H. Bao
Z. Xu
Y Shu
Keywords:
in patient
Phase (matter)
Medicine
Refractory Peripheral T-cell Lymphoma
Cancer research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]